North Star Investment Management’s Zosano Pharma Corporation ZSAN Stock Holding History

North Star Investment Management’s Portfolio ZSAN Stock Details ZSAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-714	Closed	-$6K	–	1204
2022 Q1	$6K	Hold	714	–	–	﹤0.01%	966
2021 Q4	$12K	Hold	714	–	–	﹤0.01%	876
2021 Q3	$18K	Hold	714	–	–	﹤0.01%	765
2021 Q2	$24K	Hold	714	–	–	﹤0.01%	718
2021 Q1	$31K	Hold	714	–	–	﹤0.01%	644
2020 Q4	$13K	Hold	714	–	–	﹤0.01%	745
2020 Q3	$40K	Hold	714	–	–	﹤0.01%	545
2020 Q2	$21K	Hold	714	–	–	﹤0.01%	634
2020 Q1	$14K	Buy	714 +571	+399%	+$19.1K	﹤0.01%	680
2019 Q4	$8K	Buy	+143	New	+$8.82K	﹤0.01%	861

Other funds holding ZSAN

CDIA

Capital Directions Investment Advisors Atlanta, Georgia $268M AUM 20.15% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

North Star Investment Management's ZSAN Position: Q2 2022 in Review

North Star Investment Management sold out of Zosano Pharma Corporation (ZSAN) in Q2 2022, closing a stake of 714 shares — an estimated $6K sold.

North Star Investment Management first reported a position in ZSAN in Q4 2019 and held it in 10 quarters. The position peaked at $40K in Q3 2020. 3 funds tracked by Wall St. Rank hold ZSAN as of Q2 2022.

North Star Investment Management reported no remaining Zosano Pharma Corporation position as of Q2 2022 after selling out during the quarter.
North Star Investment Management sold 714 Zosano Pharma Corporation shares in Q2 2022, an estimated $6K.
North Star Investment Management first reported a position in Zosano Pharma Corporation in Q4 2019 and held it in 10 quarters.
North Star Investment Management's Zosano Pharma Corporation position peaked at $40K in Q3 2020.
3 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q2 2022.

Based on North Star Investment Management's 13F filing for Q2 2022, filed 19 Jul 2022.